PHIBRO ANIMAL HEALTH CORP — Form 8-K
Filed July 28, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 12/100
What the filing says
Phibro's Board declared a quarterly cash dividend of $0.12 per share on both Class A and Class B common stock, payable September 23, 2026, to shareholders of record as of September 2, 2026. This is a routine quarterly dividend announcement with no change in rate or terms disclosed.
Why this rating
Standard quarterly dividend; no change communicated. Routine capital allocation disclosure immaterial to company trajectory.
See more from July 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.